Citadel Advisors’s SRAX, Inc. Class A Common Stock SRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-800
Closed -$1.22K 16255
2022
Q4
$1.22K Buy
+800
New +$1.29K ﹤0.01% 14508
2022
Q2
Sell
-10,000
Closed -$48K 14911
2022
Q1
$48K Sell
10,000
-10,400
-51% -$49.2K ﹤0.01% 12826
2021
Q4
$92K Buy
+20,400
New +$107K ﹤0.01% 12804
2021
Q3
Sell
-25,800
Closed -$140K 15373
2021
Q2
$140K Buy
25,800
+11,800
+84% +$56.8K ﹤0.01% 12576
2021
Q1
$66K Buy
+14,000
New +$58.5K ﹤0.01% 12774

Other funds holding SRAX

Citadel Advisors's SRAX Position: Q1 2023 in Review

Citadel Advisors sold out of SRAX, Inc. Class A Common Stock (SRAX) in Q1 2023, closing a stake of 397 shares — an estimated $607 sold.

Citadel Advisors first reported a position in SRAX in Q3 2017 and held it in 9 quarters. The position peaked at $431K in Q4 2021. 5 funds tracked by Wall St. Rank hold SRAX as of Q1 2023.

  • Citadel Advisors reported no remaining SRAX, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 397 SRAX, Inc. Class A Common Stock shares in Q1 2023, an estimated $607.
  • Citadel Advisors first reported a position in SRAX, Inc. Class A Common Stock in Q3 2017 and held it in 9 quarters.
  • Citadel Advisors's SRAX, Inc. Class A Common Stock position peaked at $431K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held SRAX, Inc. Class A Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.